You’re Invited to our symposium “Emerging Novel Diagnostic and Therapeutic Approaches for Leptomeningeal Metastases,” presented at the SNO/ASCO CNS conference in Denver.
More information & RSVP: https://bit.ly/4bM777e
“Emerging Novel Diagnostic and Therapeutic Approaches for Leptomeningeal Metastases,” hosted by Plus Therapeutics, will delve into cutting-edge advancements in the diagnosis and treatment of Leptomeningeal Metastases (LM).
Greg Fuller, MD, PhD, from The University of Texas MD Anderson Cancer Center and Plus Therapeutics, will kick off the session with an extensive exploration of the neuropathological aspects of Leptomeningeal Metastasis (LM). Seema Nagpal, MD, from Stanford University, will then discuss innovative cerebrospinal fluid (CSF)-based diagnostic approaches aimed at improving accuracy and early detection. Jonathan T. Yang, MD, PhD, from NYU Langone Health’s Perlmutter Cancer Center, will then outline current radiation-based therapeutic strategies, highlighting their efficacy in managing LM. Andrew Brenner, MD, PhD, from the University of Texas Health San Antonio, will conclude by exploring novel treatments involving direct intrathecal delivery of radionuclides and their potential benefits and challenges.
The session will conclude with a panel discussion, addressing attendee questions and encompassing all facets of LM management, from pathology and diagnostics to therapeutic innovations.
#BrainMets #BrainCancer #Patients #BreastCancer #LungCancer #raredisease #cancer #oncology #metastatic #braincancer #radiotherapy #therapeutics #diagnostics $PSTV
Recent Comments